Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

The Trump administration, with Kennedy as its public health executioner, is determined to roll back decades of scientific ...

“It’s still unclear whether mRNA vaccine grants will be canceled,” the scientist ... Kennedy promised during his Senate ...

A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...

We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

Investors in Moderna Inc (Symbol: MRNA) saw new options become available today, for the May 9th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.